CD274 and neoplasm: Additionally, survival curve analysis showed significantly longer survival time for patients with PD-L1highCD31low expression compared to other groups, regardless of PD-L1 expression in tumor cells or TIICs (P = .029 and P = .001, Fig. 3I and J).